Article
G protein-biased LPAR1 agonism promotes prototypic antidepressant effects
medRxiv · 2022 · Kajitani, N.; Okada-Tsucioka, M.; Inoue, A.; Miyano, K.; Masuda, T.; Boku, S.; Iwamoto, K.; Ohtsuki, S.; Uezono, Y.; Aoki, J.; Takebayashi, M.
Key facts
| Title | G protein-biased LPAR1 agonism promotes prototypic antidepressant effects |
|---|---|
| First author | Kajitani, N.; Okada-Tsucioka, M.; Inoue, A.; Miyano, K.; Masuda, T.; Boku, S.; Iwamoto, K.; Ohtsuki, S.; Uezono, Y.; Aoki, J.; Takebayashi, M. |
| Journal | medRxiv |
| Published | Nov 3, 2022 |
| DOI | 10.1101/2022.11.02.514841 |
| Devices mentioned | BK110039, K134016, K181376, K973350, K990827 |
| Product codes mentioned | IYN, JLX, KQP, PCA, IYO, ITX, KIP, KIT, LXG, NDS, NJT, PFF and 1 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1